Deep Track Capital’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.2M Sell
1,931,884
-72,094
-4% -$2.33M 0.95% 29
2025
Q4
$69.6M Buy
2,003,978
+203,978
+11% +$7.2M 1.24% 21
2025
Q3
$65.4M Hold
1,800,000
1.83% 17
2025
Q2
$56.5M Buy
1,800,000
+388,598
+28% +$12.1M 1.81% 19
2025
Q1
$41.9M Buy
1,411,402
+892,026
+172% +$26.8M 1.36% 22
2024
Q4
$15.3M Buy
+519,376
New +$16.4M 0.57% 42

Other funds holding IMCR

Deep Track Capital's IMCR Position: Q1 2026 in Review

Deep Track Capital reduced its Immunocore (IMCR) stake by 3.6% in Q1 2026, selling an estimated $2.33M and leaving 1,931,884 shares worth $58.2M. The position accounts for 0.95% of the portfolio, ranked #29.

Deep Track Capital first reported a position in IMCR in Q4 2024 and has held it in 6 quarters since. The position peaked at $69.6M in Q4 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Deep Track Capital held 1,931,884 shares of Immunocore worth $58.2M as of Q1 2026.
  • Deep Track Capital sold 72,094 Immunocore shares in Q1 2026, an estimated $2.33M.
  • Immunocore made up 0.95% of Deep Track Capital's portfolio in Q1 2026, its #29 holding.
  • Deep Track Capital first reported a position in Immunocore in Q4 2024 and has held it in 6 quarters since.
  • Deep Track Capital's Immunocore position peaked at $69.6M in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.